Study of Elderly Patients With Cancer and Seen in Consultation of Geriatric Oncology in the Nord Pas-de-Calais (CONSOG).

October 19, 2021 updated by: Centre Oscar Lambret
The aim of this study is to establish a common geriatric oncology medical database. The patients concerned are the patients having benefited from a geriatric oncology consultation in one of the participating centres. This database is designed with a view on the one hand to better describe to better understand this population and on the other hand to facilitate the conduct of future retrospective or prospective studies on this population. The constitution of this observatory of patients seen in consultation should facilitate the development of studies from the analysis of data collected, and occasional surveys by the rapid identification of cases. Data from this database could provide clinicians with valuable informative elements of descriptive epidemiology and concerning the organization of care in the geriatric oncology field.

Study Overview

Status

Completed

Conditions

Detailed Description

The study is presented during the first consultation of oncogeriatric care or after this consultation (for patients having benefited from the consultation between January 2014 and October 2014) : the patient is informed with an information note and is told that he can express its opposition to the use of its clinical data. In case of no opposition from the patient, the referent geriatrician will complete the patient form with the requested data and will forward it for computerized processing.

Study Type

Observational

Enrollment (Actual)

2914

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Arras, France
        • Centre Hospitalier D'arras
      • Boulogne sur Mer, France, 62200
        • Centre Hospitalier
      • Béthune, France, 62408
        • Centre Hospitalier
      • Douai, France
        • Centre Hospitalier, Douai
      • Dunkerque, France, 59240
        • Centre Hospitalier
      • Le Cateau-Cambrésis, France
        • Hospitalier Le Cateau-Cambresis
      • Lille, France, 59020
        • Centre Oscar Lambret
      • Lille, France, 59000
        • CHRU de Lille
      • Lille, France, 59000
        • Hopital Saint Vincent de Paul
      • Liévin, France, 62800
        • Polyclinique de Riaumont
      • Lomme, France, 59160
        • Hôpital Saint-Philibert
      • Roubaix, France
        • Clinique Saint Jean, Roubaix
      • Tourcoing, France, 59200
        • Centre Hospitalier
      • Valenciennes, France, 59300
        • Centre Hospitalier
      • Valenciennes, France, 59300
        • Centre de cancerologie les Dentellieres

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients included are patients followed in one of the participating centres and not opposing the use of their medical data.

Description

Inclusion Criteria:

  • Patient seen in consultation of geriatric oncology in one of the participating centres in Nord Pas-de-Calais.
  • Age ≥ 65 years
  • Patient having been informed and not opposing the computerized processing of its data.

Exclusion Criteria:

  • Patient having opposed the use of its medical data.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Measurement of the prevalence of different clinical criteria of interest : demographic characteristics, disease state, patient status according to the geriatric criteria (Comprehensive Geriatric Assessment (CGA)).
Time Frame: Up to 5 years
Up to 5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of the prevalence of different medical and social criteria of interest.
Time Frame: Up to 5 years
Patient's life characteristics (place of living, isolation) and the helps set up (presence of a natural caregiver, sources of professional help).
Up to 5 years
Measurement of the association between one or more factors of interest (clinical, biological and medical and social) related to a proposal to amend or not the initially proposed therapeutic strategy.
Time Frame: Up to 5 years
Up to 5 years
Percentage of patients included in trials.
Time Frame: Up to 5 years
Up to 5 years
Temporal evolutions of clinical, medical and social characteristics.
Time Frame: Up to 5 years
Up to 5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Oscar Lambret

Investigators

  • Principal Investigator: Cédric GAXATTE, MD, CHRU de Lille

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2014

Primary Completion (Actual)

September 1, 2019

Study Completion (Actual)

September 1, 2019

Study Registration Dates

First Submitted

July 2, 2015

First Submitted That Met QC Criteria

July 15, 2015

First Posted (Estimate)

July 17, 2015

Study Record Updates

Last Update Posted (Actual)

October 20, 2021

Last Update Submitted That Met QC Criteria

October 19, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CONSOG-1401

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe